Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 40.62% is 65% above its 5-year average of 24.55%, near the high end of its 5-year range (-9.94%–44.45%).
As of the fiscal period ended Friday, July 3, 2026. 0.03% above its 12-month average of 40.61%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
40.62%
EBITDA MARGIN AVG TTM
40.61%
EBITDA MARGIN AVG 3Y
33.28%
EBITDA MARGIN AVG 5Y
24.55%
EBITDA MARGIN AVG 10Y
29.60%
EBITDA MARGIN AVG 15Y
-44.60%
EBITDA MARGIN AVG 20Y
-42.32%
CURRENT VS TTM AVG
+0.03%
CURRENT VS 3Y AVG
+22.08%
CURRENT VS 5Y AVG
+65.49%
CURRENT VS 10Y AVG
+37.27%
CURRENT VS 15Y AVG
+191.08%
CURRENT VS 20Y AVG
+196.00%
Market Cap
$13.62B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$14.22B
EBITDA Margin
22.69%
TTM Avg
18.62%
3Y Avg
20.95%
5Y Avg
21.80%
Market Cap
$12.74B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$14.87B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$15.51B
EBITDA Margin
32.07%
TTM Avg
25.68%
3Y Avg
26.69%
5Y Avg
27.49%
Market Cap
$11.64B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$11.32B
EBITDA Margin
28.74%
TTM Avg
23.07%
3Y Avg
27.33%
5Y Avg
30.04%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exelixis, Inc. (EXEL) | $13.59B | 40.62% | 40.61% | 33.28% | 24.55% |
| Baxter International Inc. (BAX)vs › | $13.62B | 5.99% | 7.75% | 3.55% | 8.89% |
| Revvity, Inc. (RVTY)vs › | $13.92B | 23.07% | 26.75% | 30.05% | 32.80% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.22B | 22.69% | 18.62% | 20.95% | 21.80% |
| Tempus AI, Inc. (TEM)vs › | $12.74B | -11.84% | -53.07% | -52.51% | -64.32% |
| The Cooper Companies, Inc. (COO)vs › | $14.87B | 27.02% | 27.38% | 26.41% | 26.36% |
| Solventum Corporation (SOLV)vs › | $15.51B | 32.07% | 25.68% | 26.69% | 27.49% |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 19.75% | 19.29% | 19.87% | 21.06% |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 28.74% | 23.07% | 27.33% | 30.04% |
| DaVita Inc. (DVA)vs › | $11.16B | 19.98% | 20.97% | 19.78% | 20.10% |
Gross Margin
96.5%
EBITDA Margin
40.6%
Operating Margin
39.9%
Net Margin
35.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-07-03 | 40.62% |
| 2026-04-03 | 42.29% |
| 2026-01-02 | 40.45% |
| 2025-10-03 | 40.81% |
| 2025-07-04 | 38.88% |
| 2025-04-04 | 34.96% |
| 2024-12-31 | 30.14% |
| 2024-09-27 | 26.60% |
| 2024-06-28 | 44.45% |
| 2024-03-29 | 8.43% |
| 2023-12-31 | 18.41% |
| 2023-09-29 | -2.39% |
| 2023-06-30 | 17.85% |
| 2023-03-31 | 8.73% |
| 2022-12-31 | -9.94% |
| 2022-09-30 | 21.44% |
| 2022-07-01 | 21.10% |
| 2022-04-01 | 24.65% |
| 2021-12-31 | 26.28% |
| 2021-10-01 | 17.18% |
| 2021-07-02 | 32.89% |
| 2021-04-02 | -0.51% |
| 2020-12-31 | 9.89% |
| 2020-10-02 | -17.41% |
| 2020-07-03 | 29.96% |
| 2020-04-03 | 24.23% |
| 2019-12-31 | 35.76% |
| 2019-09-27 | 43.58% |
| 2019-06-28 | 39.41% |
| 2019-03-29 | 40.15% |
| 2018-12-31 | 49.71% |
| 2018-09-28 | 56.29% |
| 2018-06-29 | 46.52% |
| 2018-03-30 | 54.95% |
| 2017-12-31 | 31.46% |
| 2017-09-29 | 53.41% |
| 2017-06-30 | 27.67% |
| 2017-03-31 | 25.30% |
| 2016-12-31 | 50.44% |
| 2016-09-30 | 12.16% |
| 2016-07-01 | -68.71% |
| 2016-04-01 | -317.02% |
| 2015-12-31 | -314.52% |
| 2015-10-02 | -359.27% |
| 2015-07-03 | -386.55% |
| 2015-04-03 | -239.27% |
| 2014-12-31 | -570.51% |
| 2014-09-26 | -789.27% |
| 2014-06-27 | -931.01% |
| 2014-03-28 | -1314.78% |
| 2013-12-31 | -1351.48% |
| 2013-09-27 | -1009.13% |
| 2013-06-28 | -426.02% |
| 2013-03-29 | -343.03% |
| 2012-12-31 | -516.10% |
| 2012-09-30 | -180.37% |
| 2012-06-29 | -400.82% |
| 2012-03-30 | -113.79% |
| 2011-12-31 | 57.19% |
| 2011-09-30 | 63.00% |
| 2011-07-01 | -49.77% |
| 2011-04-01 | -60.74% |
| 2010-12-31 | -29.04% |
| 2010-10-01 | -3.31% |
| 2010-07-02 | -47.97% |
| 2010-04-02 | -105.17% |
| 2009-12-31 | -61.86% |
| 2009-10-02 | -24.92% |
| 2009-07-03 | -127.21% |
| 2009-04-03 | -132.35% |
| 2008-12-31 | -121.39% |
| 2008-09-26 | -138.13% |
| 2008-06-27 | -149.24% |
| 2008-03-28 | -155.51% |
| 2007-12-31 | -135.43% |
| 2007-09-28 | -148.10% |
| 2007-06-29 | -122.51% |
| 2007-03-30 | -108.50% |
| 2006-12-31 | -101.21% |
| 2006-09-30 | -116.64% |
| 2006-06-30 | -94.65% |
| 2006-03-31 | -146.10% |
| 2005-12-31 | -174.65% |
| 2005-09-30 | -161.97% |
| 2005-06-30 | -15.42% |
| 2005-03-31 | -174.86% |
| 2004-12-31 | -296.26% |
| 2004-09-30 | -177.72% |
| 2004-06-30 | -195.84% |
| 2004-03-31 | -201.54% |
| 2003-12-31 | -134.00% |
| 2003-09-30 | -167.06% |
| 2003-06-30 | -154.63% |
| 2003-03-31 | -155.53% |
| 2002-12-31 | -119.77% |
| 2002-09-30 | -185.15% |
